About Product Pipeline Publications Contact


ANDY GOREN, MDPresident | Chief Medical Officer

Prof. Goren currently serves as a Professor of Dermatology at the University of Rome "G.Marconi", Italy as well as a visiting Professor at the Department of Dermatology and Venereology, Clinical Hospital Center Sestre Milosrdnice in Zagreb, Croatia.

Prof. Andy Goren has over 20 years of experience in research, development and commercialization of breakthrough therapeutics and diagnostics.

Among the list of many firsts in dermatology, Prof. Goren was the first to develop a clinical genetic test for predicting androgenetic alopecia, the first to discover epigenetic markers predicting anti-androgen therapy response in female androgenetic alopecia, the first to develop a clinical acne vulgaris antibiotic response test based on P. Acnes bacterial genomics, and the first to develop a rapid test for predicting minoxidil response in androgenetic alopecia.

Prof. Goren is actively involved in the development, commercialization, and listing of several drugs and medical devices including new therapies for female pattern hair loss, chemotherapy induced alopecia, excessive hair shedding, and female sexual dysfunction. His latest research involves the development of dermatology therapies based on genetically modified organisms.

Prof. Goren has published dozens of manuscripts in dermatology. He is an honorary as well as ordinary member of several dermatology societies world-wide as well as a regular lecturer at dermatology congresses around the world. He held numerous appearances and interviews on mainstream TV, radio, and prestigious newspapers.


Dr. Sharon Keene, MDMedical Director

Dr. Sharon Keene is a board certified general surgeon, who completed her surgical training at the University of Arizona in Tucson. She has subsequently specialized in the medical and surgical treatment of hair loss for men and women. 

For the past 2 decades she has gained professional acclaim, using her surgical knowledge to advance techniques and improve cosmetic outcomes. Dr. Keene has shared her expertise through lecturing, teaching and authorship of medical articles and has received many professional awards for her work in hair restoration. She has been actively involved in research to improve diagnosis and treatment of female hair loss, by co-developing and co-authoring a pilot study on epigenetic influences on the androgen receptor gene and response to finasteride therapy in female hair loss. Since the completion of that project, she has written and lectured on the various environmental and dietary influences that may be affecting human epigenetics and increasing the rate and expression of androgenetic alopecia. Additionally, Dr. Keene has developed surgical instruments and tools to improve the ergonomics and efficiency of surgery. 

As part of her commitment to peer education, she has participated in various capacities and on various educational committees for the International Society of Hair Restoration Surgeons (ISHRS) including: scientific chairman for the annual scientific committee (2007), chairman of the evidence based medicine task force (2009-10), member continuing medical education committee, current chairman of the finance committee and member of the expert subcommittee panel on best practices.  She is currently the treasurer and an active member of the ISHRS executive committee. Dr. Keene served as chief medical officer for Dermagenoma from 2008-11, a medical genomics company which provided genetic tests related to diagnosis and treatment of dermatologic and associated conditions such as androgenetic alopecia, psoriatic arthritis, etc. She also serves in a pro bono capacity as a member of the health authority advisory board to a small rural clinic, Elbowoods Memorial Health Center, in North Dakota. She currently practices hair restoration surgery at Physician’s Hair Institute in Tucson, AZ.


John McCoyVice President, Research & Development

Dr. John McCoy is head of the research and development team at Applied Biology. He has over 15 years of laboratory research experience at many of California's premier institutions, including UCLA, UCSD and UC Berkeley.

Dr. McCoy has authored several original patents and scholarly articles for publication in peer-reviewed scientific journals. He is a member of the American Chemical Society, the Biophysical Society, and the Society for Investigative Dermatology. Dr. McCoy was a postdoctoral fellow at the Jules Stein Eye Institute (UCLA) where he was the recipient of the prestigious Gerald Oppenheimer Post Doctoral Fellowship and the National Institutes of Heath Vision Science Training Grant. Currently, Dr. McCoy's research is focused on the development of novel topical drugs for application in many fields including dermatology, women’s health, and oncology.


Monica NaegleDirector of Finance & Operations, International & Business Development

Monica Naegle is Applied Biology’s Director of Finance and Operations, International and Business Development. Ms. Naegle oversees day-to-day business operations, guides investment and business development decisions both internationally and domestically, and supports and develops the necessary framework for marketing efforts and all project management. She is responsible for overseeing Applied Biology’s product R&D and shaping the company’s long-term fiscal and operational manufacturing strategies. Additionally, Monica plays a key roll in the implementation and compliance of Applied Biology’s clinical studies. Her clinical study engagement spans subject screening, consent and registration, compilation and submission of data, monitoring of study compliance, and maintenance of data submission system.

Ms. Naegle joined Applied Biology in 2011 with 30 years experience in business, spanning finance, manufacturing, airline, hospitality, engineering, security, and construction industries. Monica grew up speaking, reading and writing both English and Castilian Spanish and maintains fluency in both languages today. On her off time, Monica is pleasantly busy with two teenage girls, attending dance competitions or functions and water polo games. Ms. Naegle earned a Bachelor of Science Degree in Business with an emphasis in Math from the University of California, San Diego.


RON SIMDirector of Pharmacy

Dr. Ron Sim is a clinical pharmacist with experience in diverse fields such as autoimmune disorders, primary immune deficiencies, infectious disease, critical care, pediatrics, and nuclear medicine. He also has extensive research experience at UCSD and USC in molecular cell biology, biophysics, and clinical and experimental therapeutics, and is authored in peer-reviewed scientific journals.

Outside of his work at Applied Biology, he is currently engaged in the management of patients receiving biologic pharmaceutical therapies in the alternate care setting.


LORIE WOLFDirector of Marketing & Creative

As Director of Marketing / Creative for Applied Biology, Ms. Wolf oversees the establishment and execution of Applied Biology’s marketing strategy, brand identity, web site design, packaging, advertising campaigns, and corporate communications.

Lorie has over 20 years experience in advertising, design, and marketing and has received a host national awards for her outstanding work in art direction. Ms. Wolf has built a highly successful consulting career with a top-tier clients, including DermaGenoma, Microsoft, dwell Magazine, Hilton Hotels, Sea World, San Diego Padres, Providian Financial, Warner Brothers, O’Donnell/Atkins, Johnson Capital, IDG, CMP, Sun Microsystems, Miller Freeman Publishing and more. Ms. Wolf obtained a Bachelor’s Degree in Fine Arts from the University of Arizona.


Board of Directors


As a member of Applied Biology’s Board of Directors, Mr. Brandt is integral to the Company’s strategic business objectives. Educated at Harvard, Len brings an extensive background in healthcare-related investment funds and experience from the venture capital field to Applied Biology.

As General Partner at Norwest Ventures, Mr. Brandt led the fund’s investment activity for ten years in all areas of healthcare. He was Partner and Co-founder of Embro Vascular, the dominant device technology for least invasive harvesting of saphenous veins for heart bypass surgery marketed by Boston Scientific, Guidant, and Macquet. Along side the founders of Home Diagnostics, Inc., the team successfully engineered a company turn-around that led to its sale to Nipro, Inc and a return to founders of almost $100MM. Additionally, Mr. Brandt was Founder and CEO of CNS Response, a big data translational database guiding medication selection in psychiatry. At CNS he defined the vision and core offering, was primary inventor on several patents leveraging off of the initial application, and organized all financings including reverse merge into public company with associated PIPE financing. Currently, he is involved with several young ventures seeking to “do well by doing good”.